Suvretta Capital Management, LLC Arcutis Biotherapeutics, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.28 Billion
- Q1 2025
A detailed history of Suvretta Capital Management, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 11,422,978 shares of ARQT stock, worth $160 Million. This represents 7.82% of its overall portfolio holdings.
Number of Shares
11,422,978
Previous 11,399,138
0.21%
Holding current value
$160 Million
Previous $159 Million
12.51%
% of portfolio
7.82%
Previous 6.61%
Shares
9 transactions
Others Institutions Holding ARQT
# of Institutions
250Shares Held
126MCall Options Held
605KPut Options Held
170K-
Jennison Associates LLC11.4MShares$159 Million0.13% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$153 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$123 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$95.3 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $841M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...